Product NDC: | 64980-130 |
Proprietary Name: | LEVOCARNITINE |
Non Proprietary Name: | LEVOCARNITINE |
Active Ingredient(s): | 330 mg/1 & nbsp; LEVOCARNITINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64980-130 |
Labeler Name: | Rising Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076858 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040920 |
Package NDC: | 64980-130-09 |
Package Description: | 9 BLISTER PACK in 1 BOX (64980-130-09) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 64980-130-09 |
Proprietary Name | LEVOCARNITINE |
Package Description | 9 BLISTER PACK in 1 BOX (64980-130-09) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 64980-130 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LEVOCARNITINE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040920 |
Marketing Category Name | ANDA |
Labeler Name | Rising Pharmaceuticals, Inc. |
Substance Name | LEVOCARNITINE |
Strength Number | 330 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Carnitine [Chemical/Ingredient],Carnitine Analog [EPC] |